Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Race Oncology launches two clinical programs for RC220 targeting acute myeloid leukemia and EGFR-mutated lung cancer.
Race Oncology has launched two new clinical programs for its drug RC220, targeting acute myeloid leukemia and EGFR-mutated lung cancer, based on new insights into its mechanism that may streamline regulatory approval.
The moves expand the company’s pipeline into high-need cancer areas where treatment resistance is common.
Recce Pharmaceuticals announced the passing of its founder, Dr Graham JH Melrose, a key figure in developing its anti-infective technology platform.
Meanwhile, AuMEGA Metals began diamond drilling at its Cape Ray gold project in Canada, targeting a major airborne EM anomaly along the country’s largest known gold structure.
Lindian Resources appointed Robert Rickie as commercial and supply manager for its Malawi rare earths project, and Terrain Minerals is preparing a 4,500-meter drilling campaign at its Lightning gold prospect in Western Australia.
Race Oncology lanza dos programas clínicos para RC220 dirigidos a la leucemia mieloide aguda y al cáncer de pulmón mutado por EGFR.